| 申请类型 | 申请号 | 药品名称 | 活性成分 | 活性成分中文 | 执行时间 | 持有公司 | 说明书 |
|---|---|---|---|---|---|---|---|
| BLA | 761125 | BEOVU | brolucizumab-dbll | 查看 | 2019-10-08 | NOVARTIS PHARMS CORP | 查看 |
| BLA | 761122 | NUCALA | MEPOLIZUMAB | 查看 | 2019-09-13 | GLAXOSMITHKLINE | 查看 |
| BLA | 761122 | NUCALA | MEPOLIZUMAB | 查看 | 2019-09-13 | GLAXOSMITHKLINE | 查看 |
| BLA | 761122 | NUCALA | MEPOLIZUMAB | 查看 | 2019-06-07 | GLAXOSMITHKLINE | 查看 |
| BLA | 761121 | POLIVY | POLATUZUMAB VEDOTIN-PIIQ | 查看 | 2019-06-10 | GENENTECH | 查看 |
| BLA | 761116 | ELZONRIS | TAGRAXOFUSP-ERZS | 查看 | 2018-12-21 | STEMLINE THERAPEUTICS INC | 查看 |
| BLA | 761112 | CABLIVI | CAPLACIZUMAB-YHDP | 查看 | 2019-02-06 | ABLYNX NV | 查看 |
| BLA | 761108 | ULTOMIRIS | RAVULIZUMAB-CWVZ | 查看 | 2018-12-21 | ALEXION PHARM | 查看 |
| BLA | 761107 | GAMIFANT | EMAPALUMAB-LZSG | 查看 | 2018-11-21 | NOVIMMUNE S.A. | 查看 |
| BLA | 761106 | HERCEPTIN HYLECTA | TRASTUZUMAB;HYALURONIDASE-OYSK | 查看 | 2019-02-28 | GENENTECH INC | 查看 |
| BLA | 761105 | SKYRIZI | RISANKIZUMAB-RZAA | 查看 | 2019-04-23 | ABBVIE INC | 查看 |
| BLA | 761104 | LUMOXITI | MOXETUMOMAB PASUDOTOX-TDFK | 查看 | 2019-01-29 | ASTRAZENECA AB | 查看 |
| BLA | 761104 | LUMOXITI | MOXETUMOMAB PASUDOTOX-TDFK | 查看 | 2018-09-13 | ASTRAZENECA AB | 查看 |
| BLA | 761103 | RUXIENCE | RITUXIMAB-PVVR | 查看 | 2019-07-23 | PFIZER INC | 查看 |
| BLA | 761102 | ASPARLAS | CALASPARGASE PEGOL-MKNL | 查看 | 2019-09-05 | SERVIER PHARMA LLC | 查看 |
| BLA | 761102 | ASPARLAS | CALASPARGASE PEGOL-MKNL | 查看 | 2018-12-20 | SERVIER PHARMA LLC | 查看 |
| BLA | 761100 | ONTRUZANT | TRASTUZUMAB-DTTB | 查看 | 2019-01-18 | SAMSUNG BIOEPIS CO LTD | 查看 |
| BLA | 761099 | ZIRABEV | BEVACIZUMAB-BVZR | 查看 | 2019-06-28 | PFIZER INC | 查看 |
| BLA | 761097 | LIBTAYO | CEMIPLIMAB-RWLC | 查看 | 2019-01-22 | REGENERON PHARMACEUTICALS | 查看 |
| BLA | 761097 | LIBTAYO | CEMIPLIMAB-RWLC | 查看 | 2018-10-04 | REGENERON PHARMACEUTICALS | 查看 |